在中年卵巢切除的老鼠中, Estradiol 不能保护血管新素 II 诱导的高血压
A P O Leite1,2, I Pires Dos Santos2,3, Y Zha2,3
1Department of Pharmacology, Tulane School of Medicine, New Orleans, Louisiana, USA.
Physiological reports
|November 8, 2025
概括
雌激醇 (E2) 激素疗法可能不会保护绝经后老鼠的脏和心脏损伤. 预先存在的高血压似乎限制了E2的保护性益处,强调了更年期心血管健康的重要性.
科学领域:
- 内分泌学 在内分泌学.
- 心血管科学 心血管科学
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 更年期与心血管和脏保护的丧失有关.
- 激素治疗 (HT) 可能会带来好处,但其有效性可能会受到更年期开始时的健康状况的影响.
- 以前存在的高血压可能会削弱雌激素治疗的保护作用.
研究的目的:
- 在更年期大鼠模型中,研究是否先前存在的高血压会减弱雌激醇 (E2) 的脏,心脏和血管保护作用.
- 确定高血压和E2治疗对心血管和功能以及氧化应激标志物的影响.
主要方法:
- 卵巢切除 (OVX) 的雌性大鼠在更年期建模之前注入了血管素II (ANG) 来诱导高血压.
- 鼠在OVX后接受了E2或车载治疗.
- 测量包括血压,功能 (蛋白尿,GFR),心脏缩和大动脉氧化应激标志物 (NOX4 mRNA).
主要成果:
- ANG输液成功诱导高血压,蛋白尿和增加氧化应激.
- E2治疗减少了体重,增加了骨矿物质含量,并预防了子宫缩.
- 虽然E2减轻了心脏缩,但它加剧了蛋白尿症,降低了GFR,并且没有减少高血压大脑大动脉NOX4的老鼠.
结论:
- 在这种高血压的OVX大鼠模型中,E2未能提供脏和血管保护.
- 这些发现强调,更年期激素治疗的好处可能在患有先前心血管疾病 (如高血压) 的个体中是有限的.
相关概念视频
01:25Antihypertensive Drugs: Direct Renin Inhibitors
1.3K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.3K
01:33Hormonal Regulation
35.7K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
35.7K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
902
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
902
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
2.4K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.4K
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.3K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.3K
01:29Hypertension II: Pathophysiology
765
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
765